Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9562039
APP PUB NO 20160009698A1
SERIAL NO

14770206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALMIRALL S ABARCELONA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carrera, Carrera Francesc Barcelona, ES 8 73
Julia, Jane Montserrat Barcelona, ES 2 38
Pajuelo, Lorenzo Francesca Barcelona, ES 2 38
Perez, Andres Juan Antonio Barcelona, ES 6 43
Prat, Quiñones Maria Barcelona, ES 6 73
Puig, Duran Carlos Barcelona, ES 25 234

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00